Moreover, BCL2 (an anti-apoptotic factor overexpressed and often mutated in DLBCL) (40) was also upregulated in our DLBCL cohort and its expression was correlated with that of CASP3 and CASP8 (two apoptosis regulators). This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.